Citations

Clear

1011 citation(s) found for "Barry, WT".

Intraoperative Management of a Hybrid Extracorporeal Membrane Oxygenation Circuit for Lung Transplantation
Harrison, Barry, Landolfo, Kevin , Makey, Ian A., Sareyyüpoğlu, Başar , Brown, Thomas E. , Johnson, James L., Thomas, Mathew , Martin, Archer Kilbourne , Fritz, Ashley Virginia , Pham, Si M.

Mayo Clinic

No container title available | August 17, 2020 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.22541/au.159769209.91814403 Get It

The use of extracorporeal circulation (ECC) for intraoperative cardiopulmonary support during lung transplantation has been increasing in the recent years. Our group previously described a novel hybrid extracorporeal membrane oxygenation (ECMO) circuit for use in lung transplantation. Our novel technique for intraoperative management of this circuit during lung transplantation is described.
Impact of Interatrial Shunts on Invasive Hemodynamics and Exercise Tolerance in Patients With Heart Failure
Griffin, Jan M. , Borlaug, Barry A. , Komtebedde, Jan , Litwin, Sheldon E. , Shah, Sanjiv J. , Kaye, David M. , Hoendermis, Elke S., Gustafsson, Finn , Wolsk, Emil , Uriel, Nir , Borlaug, Barry A , Kaye, David M , Shah, Sanjiv J , Gustafsson, Finn , Hasenfuß, Gerd , Burkhoff, Daniel

Mayo Clinic

Journal of the American Heart Association | August 15, 2020 | Volume: 9 | Issue: 17 | Pages: No page available

10.1161/jaha.120.016760 | PMID 32809903 Get It

Approximately 50% of patients with heart failure have preserved ejection fraction. Although a wide variety of conditions cause or contribute to heart failure with preserved ejection fraction, elevated left ventricular filling pressures, particularly during exercise, are common to all causes. Acute elevation in left‐sided filling pressures promotes lung congestion and symptoms of dyspnea, while chronic elevations often lead to pulmonary vascular remodeling, right heart failure, and increased risk of mortality. Pharmacologic therapies, including neurohormonal modulation and drugs that modify the nitric oxide/cyclic GMP‐protein kinase G pathway have thus far been limited in reducing symptoms or improving outcomes in patients with heart failure with preserved ejection fraction. Hence, alternative means of reducing the detrimental rise in left‐sided heart pressures are being explored. One proposed method of achieving this is to create an interatrial shunt, thus unloading the left heart at rest and during exercise. Currently available studies have shown 3‐ to 5‐mm Hg decreases of pulmonary capillary wedge pressure during exercise despite increased workload. The mechanisms underlying the hemodynamic changes are just starting to be understood. In this review we summarize results of recent studies aimed at elucidating the potential mechanisms of improved hemodynamics during exercise tolerance following interatrial shunt implantation and the current interatrial shunt devices under investigation.
Shock Severity and Hospital Mortality In Out of Hospital Cardiac Arrest Patients Treated With Targeted Temperature Management
Burstein, Barry , Ahmed, Abdelrahman , Burstein, Barry J, Tabi, Meir , Dezfulian, Cameron , Kashani, Kianoush , Jentzer, Jacob C.

Mayo Clinic

Shock | August 7, 2020 | Volume: 55 | Issue: 1 | Pages: 48-54

10.1097/shk.0000000000001600 | PMID 32769819 Get It

ABSTRACT Background: Shock in patients resuscitated after out of hospital cardiac arrest (OHCA) is associated with an increased risk of mortality. We sought to determine the associations between lactate level, mean arterial pressure (MAP), and vasopressor/inotrope doses with mortality. Methods: Retrospective cohort study of adult patients with OHCA of presumed cardiac etiology treated with targeted temperature management (TTM) between December 2005 and September 2016. Multivariable logistic regression was performed to determine predictors of hospital death. Results: Among 268 included patients, the median age was 64 (55, 71.8) years, including 27% females. OHCA was witnessed in 89%, OHCA rhythm was shockable in 87%, and bystander CPR was provided in 64%. Vasopressors were required during the first 24 h in 60%. Hospital mortality occurred in 104 (38.8%) patients. Higher initial lactate, peak Vasoactive-Inotropic Score (VIS), and lower mean 24-h MAP were associated with higher hospital mortality (all P < 0.001). After multivariable regression, both higher initial lactate (adjusted OR 1.15 per 1 mmol/L higher, 95% CI 1.00–1.31, P = 0.03) and higher peak VIS (adjusted OR 1.20 per 10 units higher, 95% CI 1.10–1.54, P = 0.003) were associated with higher hospital mortality, but mMAP was not (P = 0.92). However, patients with a mMAP < 70 mm Hg remained at higher risk of hospital mortality after multivariable adjustment (adjusted OR 9.30, 95% CI 1.39–62.02, P = 0.02). Conclusions: In patients treated with TTM after OHCA, greater shock severity, as reflected by higher lactate levels, mMAP < 70 mmHg, and higher vasopressor requirements during the first 24 h was associated with an increased rate of hospital mortality.
Obese-Inflammatory Phenotypes in Heart Failure With Preserved Ejection Fraction
Sabbah, Michael S. , Fayyaz, Ahmed, Denus, Simon de , Felker, G. Michael , Dasari, Surendra , Carter, Rickey E. , Redfield, Margaret M. , Fayyaz, Ahmed U., Carter, Rickey E , Borlaug, Barry A.

Mayo Clinic

Circulation: Heart Failure | July 29, 2020 | Volume: 13 | Issue: 8 | Pages: No page available

10.1161/circheartfailure.119.006414 | PMID 32809874 Get It

Background: Comorbidity-driven microvascular inflammation is posited as a unifying pathophysiologic mechanism for heart failure with preserved ejection fraction (HFpEF). Obesity is proinflammatory and common in HFpEF. We hypothesized that unique obesity-inflammation HFpEF phenotypes exist and are associated with differences in clinical features, fibrosis biomarkers, and functional performance. Methods: Patients (n=301) from 3 HFpEF clinical trials were studied. Unsupervised machine learning (hierarchical clustering) with obese status and 13 inflammatory biomarkers as input variables was performed. Associations of clusters with HFpEF severity and fibrosis biomarkers (PIIINP [procollagen III N-terminal peptide], CITP [C-telopeptide for type I collagen], IGFBP7 [insulin-like growth factor-binding protein-7], and GAL-3 [galectin-3]) were assessed. Results: Hierarchical clustering revealed 3 phenotypes: pan-inflammatory (n=129; 64% obese), noninflammatory (n=83; 55% obese), and obese high CRP (C-reactive protein; n=89; 98% obese). The pan-inflammatory phenotype had more comorbidities and heart failure hospitalizations; higher left atrial volume, NT-proBNP (N-terminal pro-B-type natriuretic peptide), and fibrosis biomarkers; and lower glomerular filtration rate, peak oxygen consumption, 6-minute walk distance, and active hours/day ( P <0.05 for all). The noninflammatory phenotype had the most favorable values for all measures. The obese high CRP phenotype resembled the noninflammatory phenotype except for isolated elevation of CRP and lower functional performance. Hierarchical cluster assignment was independent of CRP genotype combinations that alter CRP levels and more biologically plausible than other clustering approaches. Multiple traditional analytic techniques confirmed and extended the hierarchical clustering findings. Conclusions: Unique obesity-inflammation phenotypes exist in HFpEF and are associated with differences in comorbidity burden, HFpEF severity, and fibrosis. These data support comorbidity-driven microvascular inflammation as a pathophysiologic mechanism for many but not all HFpEF patients.
Effects of Intensive Blood Pressure Control in Patients with and without Albuminuria
Chang, Alex R. , Wei, Guo , Boucher, Robert E. , Bhatt, Udayan, Cohen, Debbie L. , Drawz, Paul E. , Punzi, Henry , Haley, William E. , Hawfield, Amret , Horwitz, Edward , Morisky, Don, Rocco, Michael V. , Wall, Barry M. , Zias, Athena, Drawz, Paul , Freedman, Barry I , Haley, William E , Rocco, Michael V , Chang, Alexander R , Kramer, Holly , Grams, Morgan Erika , Berlowitz, Dan R. , Freedman, Barry I. , McLouth, Christopher J. , Papademetriou, Vasilios , Weiner, Daniel E. , Beddhu, Srinivasan

Mayo Clinic

Clinical Journal of the American Society of Nephrology | July 15, 2020 | Volume: 15 | Issue: 8 | Pages: 1121-1128

10.2215/cjn.12371019 | PMID 32669306 Get It

Background and objectives It is unclear whether the presence of albuminuria modifies the effects of intensive systolic BP control on risk of eGFR decline, cardiovascular events, or mortality. Design, setting, participants, & measurements The Systolic Blood Pressure Intervention Trial randomized nondiabetic adults ≥50 years of age at high cardiovascular risk to a systolic BP target of <120 or <140 mm Hg, measured by automated office BP. We compared the absolute risk differences and hazard ratios of ≥40% eGFR decline, the Systolic Blood Pressure Intervention Trial primary cardiovascular composite outcome, and all-cause death in those with or without baseline albuminuria (urine albumin-creatinine ratio ≥30 mg/g). Results Over a median follow-up of 3.1 years, 69 of 1723 (4%) participants with baseline albuminuria developed ≥40% eGFR decline compared with 61 of 7162 (1%) participants without albuminuria. Incidence rates of ≥40% eGFR decline were higher in participants with albuminuria (intensive, 1.74 per 100 person-years; standard, 1.17 per 100 person-years) than in participants without albuminuria (intensive, 0.48 per 100 person-years; standard, 0.11 per 100 person-years). Although effects of intensive BP lowering on ≥40% eGFR decline varied by albuminuria on the relative scale (hazard ratio, 1.48; 95% confidence interval, 0.91 to 2.39 for albumin-creatinine ratio ≥30 mg/g; hazard ratio, 4.55; 95% confidence interval, 2.37 to 8.75 for albumin-creatinine ratio <30 mg/g; P value for interaction <0.001), the absolute increase in ≥40% eGFR decline did not differ by baseline albuminuria (incidence difference, 0.38 events per 100 person-years for albumin-creatinine ratio ≥30 mg/g; incidence difference, 0.58 events per 100 person-years for albumin-creatinine ratio <30 mg/g; P value for interaction =0.60). Albuminuria did not significantly modify the beneficial effects of intensive systolic BP lowering on cardiovascular events or mortality evaluated on relative or absolute scales. Conclusions Albuminuria did not modify the absolute benefits and risks of intensive systolic BP lowering.
A Tough Time Running Around the Block
Ezzeddine, Fatima M. , Mulpuru, Siva K. , Borlaug, Barry A. , Borlaug, Barry A , Ezzeddine, Fatima

Mayo Clinic

Circulation: Heart Failure | July 15, 2020 | Volume: 13 | Issue: 8 | Pages: No page available

10.1161/circheartfailure.120.007182 | PMID 32673504 Get It

A CT-Based Method to Determine Changes in Extravascular Lung Water with Exercise in Heart Failure with Preserved Ejection Fraction
Stewart, G.M., Johnson, Bradley D., Fermoyle, Caitlin C. , Borlaug, Barry A. , Johnson, B.D.

Mayo Clinic

A56. LEFT HEART DISEASE, METABOLISM AND OBESITY IN PULMONARY HYPERTENSION: CLINICAL STUDIES | July 7, 2020 | Volume: No volume available | Issue: No issue available | Pages: A2073-A2073

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a2073 Get It

Pulmonary Gas Transfer Dysfunction During Exercise Right Heart Catheterization in Heart Failure with Preserved Ejection Fraction: Do Lung Diffusion Limitations Contribute to the Pathogenesis of Exercise Intolerance?
Stewart, G.M., Johnson, Bradley D., Fermoyle, Caitlin C. , Borlaug, Barry A. , Johnson, B.D.

Mayo Clinic

A56. LEFT HEART DISEASE, METABOLISM AND OBESITY IN PULMONARY HYPERTENSION: CLINICAL STUDIES | July 7, 2020 | Volume: No volume available | Issue: No issue available | Pages: A2072-A2072

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a2072 Get It

Effects of microbiome rare taxa filtering on statistical analysis
Cao, Quy , Sun, Xinxin , Rajesh, Karun, Chalasani, Naga , Gelow, Kayla, Katz, Barry P., Shah, Vijay H. , Smirnova, Ekaterina , Sanyal, Arun J.

Mayo Clinic

No container title available | July 2, 2020 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-34781/v1 Get It

Abstract Background: Accuracy of microbial community detection in 16S rRNA marker-gene and metagenomic studies suffers from contamination and sequencing errors that lead to either falsely identifying microbial taxa that were not in the sample or misclassifying the taxa of DNA fragment reads. Filtering is defined as removing taxa that are present in a small number of samples and have small counts in the samples where they are observed. This approach reduces extreme sparsity of microbiome data and has been shown to correctly remove contaminant taxa in cultured "mock" datasets, where the true taxa compositions are known. Although filtering is frequently used, careful evaluation of its effect on the data analysis and scientific conclusions remains unreported. Here, we assess the effect of filtering on the alpha and beta diversity estimation, as well as its impact on identifying taxa that discriminate between disease states. Results: The effect of filtering on microbiome data analysis is illustrated on four datasets: two mock quality control datasets where same cultured samples with known microbial composition are processed at different labs and two disease study datasets. Results show that in microbiome quality control datasets, filtering reduces the magnitude of differences in alpha diversity and alleviates technical variability between labs, while preserving between samples similarity (beta diversity). In the disease study datasets, DESeq2 and linear discriminant analysis Effect Size (LEfSe) methods were used to identify taxa that are differentially expressed across groups of samples, and random forest models to rank features with largest contribution towards disease classiffcation. Results reveal that filtering retains significant taxa and preserves the model classification ability measured by the area under the receiver operating characteristic curve (AUC). The comparison between filtering and contaminant removal method shows that they have complementary effects and are advised to be used in conjunction. Conclusions: Filtering reduces the complexity of microbiome data, while preserving their integrity in downstream analysis. This leads to mitigation of the classification methods' sensitivity and reduction of technical variability, allowing researchers to generate more reproducible and comparable results in microbiome data analysis.